Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

Annabel Samimy, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Altimmune (ALT).Stay Ahead of the Market:Discover ...

Stifel analyst Annabel Samimy initiated coverage of Altimmune (ALT) with a Buy rating and $18 price target The company is developing ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose weight, gain control over their blood sugar levels, and improve their ...

Since then, I think it’s fair to say that most people have been nervous about the emergence of the next big infectious disease – be that a virus, bacterium, fungus or parasite. With COVID in ...

The findings, part of a preliminary analysis by London-based disease forecasting firm Airfinity Ltd., seek to renew the focus on the rise of preventable and climate-sensitive diseases, as well as ...

Here’s what you should know. Meet the experts: Thomas Russo, MD, a professor and chief of infectious disease at the University at Buffalo in New York. What are the COVID symptoms to look for in ...

Novo Nordisk (NYSE:NVO) has secured approval from the European Medicines Agency (EMA) for a kidney disease-related label expansion for its blockbuster drug Ozempic (semaglutide) in Europe, on ...